How Migraine Medications Are Tested
Posted on December 10 2024,
1. Testing Immediate Relief Medications (Acute Treatment)
| What's Being Tested | Previous Standards | Current Standards |
|---|---|---|
| How Often Patients Need to Have Migraine Attacks to Join the Study | 1-6 migraine attacks per month | 2-8 migraine attacks per month, <15 headache days |
| How Success is Measured (primary endpoint) |
Whether migraine attack resolved at 2 hours |
Whether pain is completely gone at 2 hours AND most bothersome symptom |
| Additional Success Measures | Just pain relief | • Complete pain relief • Relief from most bothersome symptom • Whether relief lasts for 24-48 hours |
| Side Effect Tracking | Basic tracking | Detailed reporting of all side effects |
2. Testing Preventive Medications
| What's Being Tested | Previous Standards | Current Standards |
|---|---|---|
| Who Can Participate | People with 2-6 migraine attacks monthly | People with up to 15 migraine attacks monthly |
| How Success is Measured (primary endpoint) | Counting fewer attacks | Either: • Fewer migraine attack days per month • At least 50% reduction in migraine days (should be the secondary endpoint, if not the primary) |
3. Special Cases
For People with Chronic Migraine
| What's Important | Details |
|---|---|
| Who Can Participate | People can be included even if they have medication overuse/adaptation headache |
| Success Measures (primary endpoint) | Reduction in number of moderate/severe headache days |
| Additional Benefits (secondary endpoint) | Whether migraine attacks become less frequent overall (conversion to episodic migraine) |
For Children and Adolescents
| What's Important | Details |
|---|---|
| Age Groups | Ages 6-17 allowed to participate |
| Special Requirements | • Must have had migraine attacks for at least 6 months • Parents can help report symptoms • Studies must run year-round (not just during school) |
For Migraine with Visual/Sensory/Speech or Language Symptoms (Aura)
| What's Important | Details |
|---|---|
| Minimum Requirement | At least one migraine with aura monthly |
| Success Measures | • How often auras occur (primary endpoint) • How often headaches follow the aura (secondary endpoint) |
Candesartan for Migraine Prevention: What New Research Shows
New 2026 research shows candesartan, a low-cost blood pressure pill, can prevent migraines. Here is what the evidence says about how ARBs work, dosing, safety, and who should consider them.
Read MoreFri, May 08, 26
Does the Side of Your Migraine Actually Matter?
If you've been told your migraine attacks are damaging your brain or that the side they're on predicts anxiety or PTSD, the evidence doesn't support it.
Read MoreMigraine, Menopause, and Hormonal Health
Migraine affects women three times more than men, and menopause does not always bring relief. Nearly half of women continue having migraine attacks after menopause. Learn what the research says...
Read More
